Skip to main content

Volume 24 - Issue 4 - April 2016

Department

Coding and Billing
05/23/2016
This is a Coding Solutions guest series focusing on dermatology-specific billing, coding, and documentation.  
This is a Coding Solutions guest series focusing on dermatology-specific billing, coding, and documentation.  
This is a Coding Solutions guest...
05/23/2016
The Dermatologist
Board Review
05/19/2016
The contents of these questions are taken from the Galderma Pre-Board Webinar, an online course.
The contents of these questions are taken from the Galderma Pre-Board Webinar, an online course.
The contents of these questions...
05/19/2016
The Dermatologist
Clinical Tips
05/13/2016
The Dermatologist readers offer pearls from their clinical practice.
The Dermatologist readers offer pearls from their clinical practice.
The Dermatologist readers offer...
05/13/2016
The Dermatologist
Research in Review
05/11/2016
Make sure you do not mistake signs of psoriasis in patients of color.
Make sure you do not mistake signs of psoriasis in patients of color.
Make sure you do not mistake...
05/11/2016
The Dermatologist

Column

Voices
05/22/2016
The time for change has come. 
The time for change has come. 
The time for change has...
05/22/2016
The Dermatologist
05/21/2016
Here are 5 top concerns physicians face and how real practices have handled them.
Here are 5 top concerns physicians face and how real practices have handled them.
Here are 5 top concerns...
05/21/2016
The Dermatologist
05/17/2016
Good communication is the key to all relationships, and nowhere is that more important than the relationship between physicians and patients. 
Good communication is the key to all relationships, and nowhere is that more important than the relationship between physicians and patients. 
Good communication is the key to...
05/17/2016
The Dermatologist
05/10/2016
A rare but severe skin condition is associated with the antipsychotic olanzapine, according to an FDA alert.
A rare but severe skin condition is associated with the antipsychotic olanzapine, according to an FDA alert.
A rare but severe skin condition...
05/10/2016
The Dermatologist

News

News
05/13/2016
The Skin Cancer Foundation recently announced the appointment of Dan Latore as executive director.
The Skin Cancer Foundation recently announced the appointment of Dan Latore as executive director.
The Skin Cancer Foundation...
05/13/2016
The Dermatologist

Interactive Features

FDA Alerts
05/11/2016
FDA has granted approval of a combination photodynamic therapy (PDT) treatment for actinic keratosis (AK) on the face and scalp.
FDA has granted approval of a combination photodynamic therapy (PDT) treatment for actinic keratosis (AK) on the face and scalp.
FDA has granted approval of a...
05/11/2016
The Dermatologist